PTC Therapeutics: Sephience Starts Well, But Translarna Is The Swing Factor
PTC Therapeutics: Sephience Starts Well, But Translarna Is The Swing Factor
Sterling Infrastructure: Wait For A Better Entry Point As Stock Looks Overstretched Now
Sterling Infrastructure: Wait For A Better Entry Point As Stock Looks Overstretched Now
Power Solutions International: Uncertainties Await Clarity In Q3 (Rating Downgrade)
Power Solutions International: Uncertainties Await Clarity In Q3 (Rating Downgrade)
Nasdaq 100: Still Bullish, New Price Targets (Technical Analysis)
Nasdaq 100: Still Bullish, New Price Targets (Technical Analysis)
TSPY: 13% Yield That Could Fund Your Retirement, It’s A Buy
TSPY: 13% Yield That Could Fund Your Retirement, It's A Buy
Canadian National Railway: Q3 Beat Highlights Efficiency Gains And Resilience
Canadian National Railway: Q3 Beat Highlights Efficiency Gains And Resilience
Fed Board Breaks Ranks In Both Directions Over Rate Cuts
Fed Board Breaks Ranks In Both Directions Over Rate Cuts
Nucor: Multiple Secular Growth Trends Ahead For The Steelmaker (Rating Upgrade)
Nucor: Multiple Secular Growth Trends Ahead For The Steelmaker (Rating Upgrade)
Visa targets low double-digit net revenue and EPS growth in 2026 as innovation accelerates
Visa targets low double-digit net revenue and EPS growth in 2026 as innovation accelerates